Artrya Limited (ASX:AYA) Receives FDA Clearance for Salix® Coronary Anatomy
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Artrya Limited (ASX:AYA) secures FDA clearance for Salix® Coronary Anatomy, facilitating its commercial launch in the US market.
Avecho Biotechnology Limited (ASX:AVE) receives a US$3M upfront licensing fee from Sandoz AG for its CBD treatment for insomnia in Australia.
xReality Group Limited (ASX:XRG) enters into a debt refinancing agreement with Causeway Asset Management to strengthen its financial position and support growth.
Tivan Limited (ASX:TVN) progresses joint venture with Sumitomo Corporation for the Speewah Fluorite Project, anticipating agreement execution in early April.
Incitec Pivot Limited (ASX:IPL) announces new DNEL business unit and updates on first half performance in Dyno Nobel and Fertilisers divisions.
Gibb River Diamonds Limited (ASX:GIB) lodges a mining proposal for the Neta Prospect at its Edjudina Gold Project, advancing its operational plans.
RLF AgTech Ltd (ASX:RLF) signs a supply agreement with Elders Australia, expanding its crop nutrition product distribution to over 500 locations nationwide.
Lykos Metals (ASX:LYK) secures A$0.4M through a share placement to fund exploration and development initiatives.
Strata Minerals Limited (ASX:SMX) completes its maiden drilling program at Penny South Gold Project, with assay results expected in April.
Dotz Nano Limited (ASX:DTZ) successfully demonstrates superior Direct Air Capture technology in lab-scale pilot, advancing towards commercial deployment.